Found: 115
Select item for more details and to access through your institution.
SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae367
- By:
- Publication type:
- Article
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50376-z
- By:
- Publication type:
- Article
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.
- Published in:
- PLoS Medicine, 2024, v. 21, n. 6, p. 1, doi. 10.1371/journal.pmed.1004329
- By:
- Publication type:
- Article
Invasive fungal disease in patients treated for newly diagnosed acute leukemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 695, doi. 10.1002/ajh.21776
- By:
- Publication type:
- Article
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2.
- Published in:
- Journal of Applied Laboratory Medicine, 2021, v. 6, n. 6, p. 1561, doi. 10.1093/jalm/jfab072
- By:
- Publication type:
- Article
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00610-4
- By:
- Publication type:
- Article
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00610-4
- By:
- Publication type:
- Article
Immune Control in Repeated Babesia microti Infection in a Patient With B-Cell Deficiency.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad568
- By:
- Publication type:
- Article
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38892-w
- By:
- Publication type:
- Article
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39292-w
- By:
- Publication type:
- Article
Integrative omics to detect bacteremia in patients with febrile neutropenia.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0197049
- By:
- Publication type:
- Article
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 7, p. e250, doi. 10.1093/cid/ciac724
- By:
- Publication type:
- Article
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 12, p. 1635, doi. 10.1093/cid/ciad418
- By:
- Publication type:
- Article
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 560, doi. 10.1093/cid/ciad209
- By:
- Publication type:
- Article
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 2018, doi. 10.1093/cid/ciad066
- By:
- Publication type:
- Article
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 2, p. 271, doi. 10.1093/cid/ciac780
- By:
- Publication type:
- Article
Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S5, doi. 10.1093/cid/ciac301
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e920, doi. 10.1093/cid/ciab930
- By:
- Publication type:
- Article
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 4, p. 715, doi. 10.1093/cid/ciab465
- By:
- Publication type:
- Article
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 5, p. 869, doi. 10.1093/cid/ciz048
- By:
- Publication type:
- Article
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e279, doi. 10.1093/infdis/jiae067
- By:
- Publication type:
- Article
Protein Dose-Sparing Effect of AS01<sub>B</sub> Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e405, doi. 10.1093/infdis/jiad434
- By:
- Publication type:
- Article
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 12, p. 1662, doi. 10.1093/infdis/jiad323
- By:
- Publication type:
- Article
Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06390-4
- By:
- Publication type:
- Article
Is the BCG Vaccine an Answer to Future Pandemic Preparedness?
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 201, doi. 10.3390/vaccines10020201
- By:
- Publication type:
- Article
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 9, p. 1859, doi. 10.3201/eid2809.220729
- By:
- Publication type:
- Article
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 519, p. 1, doi. 10.1126/scitranslmed.aaw1673
- By:
- Publication type:
- Article
Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 3, p. 275, doi. 10.1001/jama.2010.926
- By:
- Publication type:
- Article
Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 3, p. 510, doi. 10.1093/cid/cix325
- By:
- Publication type:
- Article
A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1733, doi. 10.1093/cid/ciu725
- By:
- Publication type:
- Article
Epstein-Barr and Other Herpesvirus Infections in Patients With Early Onset Type 1 Diabetes Treated With Daclizumab and Mycophenolate Mofetil.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 2, p. 248
- By:
- Publication type:
- Article
Invasive Fungal Disease after Remote Inoculation in Transplant Recipients.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. 1, p. NP, doi. 10.1093/cid/ciq040
- By:
- Publication type:
- Article
Diagnostic Performance of the (1→3)-β-d-Glucan Assay for Invasive Fungal Disease.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 11, p. 1650, doi. 10.1086/647942
- By:
- Publication type:
- Article
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, n. 5, p. 674, doi. 10.1086/590566
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad349
- By:
- Publication type:
- Article
Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac565
- By:
- Publication type:
- Article
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac417
- By:
- Publication type:
- Article
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 12, p. 1, doi. 10.1093/ofid/ofab563
- By:
- Publication type:
- Article
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 12, p. 1, doi. 10.1093/ofid/ofab504
- By:
- Publication type:
- Article
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 10, p. 1, doi. 10.1093/ofid/ofab441
- By:
- Publication type:
- Article
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa606
- By:
- Publication type:
- Article
87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S5, doi. 10.1093/ofid/ofz359.011
- By:
- Publication type:
- Article
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 17, p. 1518, doi. 10.2146/ajhp120599
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 3, p. 333, doi. 10.1002/art.42386
- By:
- Publication type:
- Article
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 1, p. E1, doi. 10.1002/art.42372
- By:
- Publication type:
- Article
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 5, p. e21, doi. 10.1002/art.42109
- By:
- Publication type:
- Article
American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 10, p. e60, doi. 10.1002/art.41928
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor